{
  "schemaVersion": 1,
  "contentDigest": "2c5bddd1814f134267a3615665390a902180dbfd003edd88fa94da5230dfbdc1",
  "id": "news-oct22-a2-mubadala-bio-ids-gsk-medicine-distribution-2026-10-21",
  "language": "en",
  "interfaceLanguage": "en",
  "url": "https://voltformer.com/news/mubadala-bio-ids-gsk-uae-medicines-distribution-alliance",
  "slug": "mubadala-bio-ids-gsk-uae-medicines-distribution-alliance",
  "category": "policy-standards",
  "publishDate": "2026-10-21",
  "sourceName": "Emirates News Agency (WAM)",
  "sourceUrl": "https://www.wam.ae/en/article/c2us4yj-mubadala-bio%E2%80%99s-ids-gsk-sign-strategic-partnership",
  "readingTimeMinutes": 1,
  "tags": [
    "United Arab Emirates",
    "Pharmaceuticals",
    "Distribution",
    "Healthcare"
  ],
  "content": {
    "title": "Mubadala Bio’s IDS to handle UAE portfolio of over 20 GSK medicines",
    "summary": "The alliance was signed at the Abu Dhabi Future Health Summit.",
    "sections": [
      {
        "paragraphs": [
          "Mubadala Bio’s IDS and GSK signed an alliance at the Abu Dhabi Future Health Summit. IDS will manage UAE sales, marketing, distribution and promotion for GSK General Medicines, covering a portfolio of more than 20 medicines."
        ],
        "sources": [
          {
            "name": "Emirates News Agency (WAM)",
            "url": "https://www.wam.ae/en/article/c2us4yj-mubadala-bio%E2%80%99s-ids-gsk-sign-strategic-partnership"
          }
        ]
      }
    ]
  },
  "companies": [],
  "sourceVersion": "eca705d619ef68209cee790d521cc682d43aeacfed82678d507d1ddad0dda1a3"
}